Evaluation Sub-Committee - Applications considered
- 1569 - Chitosan-based cartilage biomatrix implant (BST-CarGel), in conjunction with the marrow stimulation technique (microfracture), for repair of focal cartilage defects
- 1573 - Reproductive carrier screening for fragile X syndrome, spinal muscular atrophy and cystic fibrosis
- 1575 - Autologous fat grafting (AFG) by injection, for defects arising from breast surgery, breast cancer treatment/prevention and congenital breast deformity
- 1577 - Autologous fat grafting (AFG) for treatment of burn scars, and treatment of facial defects due to craniofacial abnormalities
- 1582 - Detection of Aquaporin-4 (AQP4) antibodies in serum of cerebrospinal fluid for diagnosis of NMO (neuromyelitis optica)
- 1586 - Transurethral Water Vapour Ablation (TUWA) for benign prostate hyperplasia (BPH)
- 1590 - Review of immunoglobulin use - Multifocal Motor Neuropathy (MMN)
- 1593 - Bovine bioinductive collagen implant (REGENETENTM)
- 1612 - Prostatic urethral lift procedure for men with benign prostate hyperplasia
- 1622 - Cardiac ablation devices for use in ventricular arrhythmia and supraventricular tachycardia
- 1623 - LuxturnaTM (voretigene neparvovec) for the treatment of biallelic RPE-65-mediated inherited retinal dystrophies
- 1625 - Dinutuximab beta for treatment of high risk neuroblastoma